Joe Cook, Jr.

Co-Founder at Mountain Group Capital LLC

Joe Cook, Jr.

Joe Cook, Jr.

Co-Founder at Mountain Group Capital LLC

Overview
Career Highlights

Nusirt Sciences, Inc.
Amylin Pharmaceuticals, Inc.
Mountain Group Capital LLC

RelSci Relationships

991

Primary Location

Nashville, TN

Number of Boards

28

Birthday

1942

Age

77

Number of Awards

1

Relationships
RelSci Relationships are individuals Joe Cook, Jr. likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Castle Biosciences, Inc.

Relationship likelihood: Strong

Principal & Co-Founder at Mountain Group Capital LLC

Relationship likelihood: Strong

President & Chief Operating Officer at Appello Pharmaceuticals, Inc.

Relationship likelihood: Strong

Principal & Co-Founder at Mountain Group Capital LLC

Relationship likelihood: Strong

Founder at Nusirt Sciences, Inc.

Relationship likelihood: Strong

Former President at Life Science Advisors LLC

Relationship likelihood: Strong

Chief Executive Officer at Agtech Accelerator Corp.

Relationship likelihood: Strong

Founding Partner at Polaris Partners

Relationship likelihood: Strong

Chairman of the Board & Chief Executive Officer at Equillium, Inc.

Relationship likelihood: Strong

Chairman & President at Diabetes Care Group, Inc.

Relationship likelihood: Strong

Paths to Joe Cook, Jr.
Potential Connections via
Relationship Science
You
Joe Cook, Jr.
Co-Founder at Mountain Group Capital LLC
Education
BS in Engineering with High Honors
Class of 1965

The University of Tennessee (also referred to as the University of Tennessee, Knoxville, UT Knoxville, UT, or UTK) is a public sun-grant and land-grant university headquartered at Knoxville, Tennessee, United States. Founded in 1794, two years before Tennessee entered the Union as the 16th state, it is the flagship institution of the statewide University of Tennessee system with nine undergraduate colleges and eleven graduate colleges and hosts almost 28,000 students from all 50 states and more than 100 foreign countries.

Career History
Co-Founder
2002 - Current

Mountain Group Partners (\"MGP\") is an investor dedicated to investing in and actively guiding transformational businesses in the Life Sciences and Technology sectors. Founded in 2002, MGP principals have invested in more than 30 companies in these sectors.Currently, MGP is investing funds from (1) MGC Venture Partners 2013, LP, (2) Limestone Fund, a fund chosen in 2009 by the State of Tennessee to invest state funds to drive economic growth in Tennessee, and (3) private capital accounts.Mountain Group Partners seeks to invest in seed and early stage companies focused on two major sectors: Life Sciences and Technology. Within the Life Sciences sector, the Fund primarily focuses on investments in the diagnostics, medical device, and nutraceuticals & expedited drug development sub-sectors. Within the Technology sector, the Fund has a concentration in healthcare technology, business services and consumer technology companiesMountain Group Partners seeks to invest in Small/Middle Market Companies ?MGP targets private businesses or divisions of companies typically with revenue between $1 million and $10 million•History of Cash Flow ?Acquisition candidates should have a history of strong cash flow•Quality Management Teams ?MGP seeks to partner with strong management teams that have a proven record of success and who wish to become co-owners with MGP•Basic Industries ?Manufacturing, distribution and basic service companies with strong market shares in focused niches are targeted.

Executive Chairman & President
Current

Nusirt Sciences, Inc manufactures food ingredients for healthcare markets. It has technology platform that uses a patented combination of leucine, an essential amino acid, and existing human medicines targeted at diseases that may be addressed by activating sirtuin pathways. The company was founded by Michael Zemel in 2007 and is headquartered in Nashville, TN.

Director & Principal
Tenure Unconfirmed

Limestone Fund LLC seeks investment opportunities in companies located in the US. The fund targets companies operating in the fields of life sciences and consumer technology. It provides financing for early-stage capital requirements.

Boards & Committees
Executive Chairman & President
Current

Nusirt Sciences, Inc manufactures food ingredients for healthcare markets. It has technology platform that uses a patented combination of leucine, an essential amino acid, and existing human medicines targeted at diseases that may be addressed by activating sirtuin pathways. The company was founded by Michael Zemel in 2007 and is headquartered in Nashville, TN.

Executive Chairman
Current

Appello Pharmaceuticals, Inc. operates as a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson's disease. The company is headquartered in Nashville, TN.

Member, Scientific Advisory Board
Current

Hatteras Venture Partners invests in early-stage companies focused on the following sectors: biopharmaceuticals, medical devices, diagnostics and related opportunities in human medicine. They invest in companies located in the research-driven regions of North Carolina and the Southeastern United States.

Member, Board of Directors
Prior - 2019

Mercy Multiplied values every person's life and believes in his or her future. Young women come to a Mercy residence because they are desperate to fill the emptiness in their lives that the world has failed to satisfy. God calls Mercy to respond to this need by providing a safe, Christ-centered program free of charge that allows young women the ability to find and embrace hope for the future. For those unable to enter a Mercy home, Mercy provides resources to churches, groups, and individuals to equip the journey of freedom. By accepting Christ's love and forgiveness, those who commit to a Mercy program are freed from past circumstances and equipped to take hope out into the world.

Director
2010 - Prior

Life Science Tennessee operates tennessee biotechnology association. It conducts business and economic development activities. The firm advocates on behalf of the industry. It provides a network for the exchange of ideas, information and opportunities. The company is headquartered in Nashville, TN.

Member, Board of Directors
Prior

On a foundation of Christian faith, Martha O'Bryan Center empowers children, youth, and adults in poverty to transform their lives through work, education, employment, and fellowship.

Political Donations
$2,500
2011

Former Senator from Tennessee

$500
2006

Former Senator from Tennessee

$200
2004

The National Republican Senatorial Committee (NRSC) is the only national organization solely devoted to electing Republicans to the U.S. Senate. The NRSC provides invaluable support and assistance to current and prospective Republican U.S. Senate candidates in the areas of budget planning, election law compliance, fundraising, communications tools and messaging, research and strategy.

Transactions
Details Hidden

Nusirt Sciences, Inc. raised money in a private placement transaction

Details Hidden

Nusirt Sciences, Inc. raised money in a private placement transaction

Details Hidden

Nusirt Sciences, Inc. raised money in a private placement transaction

Investments
Details Hidden

At Ironwood, we seek to transform knowledge into medicines that make a difference for patients. Patients shape our business. They influence our drugmaking process, helping us to understand and address their unmet medical needs, whether we’re creating a new medicine or tackling the equally challenging task of delivering that medicine to people around the world. Our employees shape our success. Since our founding in 1998, each of our employees has held shares in the company. Being owners of Ironwood means we are all careful stewards of our resources: we take a data-driven approach in which we celebrate definitive answers – whether those answers support holding steady or changing course – and we challenge every program to earn its way forward. Our discovery and development processes have generated a product that’s approved in the United States and in the European Union, as well as a robust pipeline. As we continue to do drugmaking well, we hope to inspire the support of our shareholders and earn the right to do it again – building an enduring pharmaceutical company that understands and addresses people’s needs.

Awards & Honors
2009
The Philadelphia Pinnacle Award
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Joe Cook, Jr.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Joe Cook, Jr.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Joe Cook, Jr..